%D8%A8%D9%88%D8%B3%D8%A7%D9%83%D9%88%D9%86%D8%A7%D8%B2%D9%88%D9%84%D9%BE%D9%88%D8%B3%D8%A7%DA%A9%D9%88%D9%86%D8%A7%D8%B2%D9%88%D9%84PosaconazolPosaconazolePosaconazol%D9%BE%D9%88%D8%B3%D8%A7%DA%A9%D9%88%D9%86%D8%A7%D8%B2%D9%88%D9%84PosaconazolePosaconazolPosaconazol%D0%9F%D0%BE%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%B0%D0%B7%D0%BE%D0%BBPosakonazolPosakonazolPosakonazol%D0%9F%D0%BE%D0%B7%D0%B0%D0%BA%D0%BE%D0%BD%D0%B0%D0%B7%D0%BE%D0%BBPosaconazoleQ906453
about
A Study to Evaluate Efficacy and Safety of Four Posaconazole Regimens With Placebo and Terbinafine in the Treatment of Toenail Onychomycosis (Study P05082AM2)(COMPLETED)POS vs FLU for First Line Treatment of Coccidioidomycosis (Study P04558Am1)(COMPLETED)Pharmacokinetics, Safety, and Tolerability of Intravenous Posaconazole Solution Followed by Oral Posaconazole Suspension in Subjects at High Risk for Invasive Fungal Infections (P05520)Posaconazole Pharmacokinetics in Patients Receiving Chemotherapy or Stem Cell TransplantsRegistry of Patients Treated With Systemic Mold-Active TriazolesPharmacokinetics of Posaconazole in Allogeneic Transplant Patients With MucositisPharmacokinetic Analysis of Posaconazole in Lung Transplant RecipientsPharmacokinetics (PK) Drug Interaction Study of Milademetan and Itraconazole or Posaconazole in Healthy ParticipantsPosaconazole vs Itraconazole in Preventing IFD Post-HSCTPosaconazole Prophylaxis During ATG Treatment for hMDS/AA PatientsHDM201 Added to CT in R/R or Newly Diagnosed AMLPharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML)Peripheral Blood Stem Cell Transplantation From Family Haploidentical Donors in Patients With Myelodysplastic Syndrome and Acute Leukemia Under Primary Prophylaxis With PosaconazoleStudy of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
P4844
Efficacy of posaconazole in a murine model of disseminated infection caused by Apophysomyces variabilis.Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year periodEfficacy of posaconazole in murine experimental sporotrichosisPosaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring.Posaconazole: when and how? The clinician's view.Posaconazole: the case for therapeutic drug monitoring.Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy.Factors influencing the pharmacokinetics of prophylactic posaconazole oral suspension in patients with acute myeloid leukemia or myelodysplastic syndrome.In vitro and in vivo activities of posaconazole and amphotericin B in a murine invasive infection by Mucor circinelloides: poor efficacy of posaconazole.Cost-effectiveness of posaconazole versus fluconazole for prevention of invasive fungal infections in U.S. patients with graft-versus-host disease.Effect of posaconazole on the pharmacokinetics of simvastatin and midazolam in healthy volunteers.Impact of benzodiazepines on posaconazole serum concentrations. A population-based pharmacokinetic study on drug interaction.An atypical cause of sporotrichosis in a catMicafungin prophylaxis for acute leukemia patients undergoing induction chemotherapyDiagnosis of Rhinocerebral Mucormycosis by Treatment of Cavernous Right Internal Carotid Artery Occlusion With Mechanical Thrombectomy: Special Case Presentation and Literature ReviewThe clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivoMucor menace in an immunocompetent young male after dental manipulationSuccessful treatment of cutaneous zygomycosis with extensive surgical debridement and oral posaconazole in an immunocompetent patientStudy of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
P921
Q61917941-B3EEF51C-9875-4FBF-99EE-643716CB2E26Q61921701-FEA8B689-3EA8-48B1-8B84-7F8A6DF1522CQ61938181-38DDD820-6825-4124-B447-0BFC701CC608Q62040535-2D49512F-64DE-4978-9532-0A7002C984BFQ63229487-5C6E4DF9-4478-44D2-AD86-DC6C524C325AQ63322254-7F2614EC-EB5E-4222-BA64-9DE834CF6BD6Q63322408-1009E51B-2BC3-427B-9F89-3ED50146A203Q63394024-07E656D9-8169-47E1-95F7-5ED3F722E21AQ63394807-E2367EE0-46DF-47A5-A4B7-4B95E4C8A2B2Q63535108-52640AFA-4479-432C-A89A-2B84D6ACC223Q63592217-89C294F8-6FAE-4DF9-ACB9-3EFCF98C89DBQ63592601-5FBA1B67-6472-44CC-A783-B4A8022BE85CQ63613411-461F6BEE-8F45-4A0D-8EA2-0C24C6CA6713Q63813463-E06D5283-903D-4C4D-AB10-EB08677CC0C4Q93329002-D5420D29-D075-4D37-9931-3CF45966BAF8
P4844
Q34262150-AD4E36D9-6F36-4D90-98E9-CD8508F56F0EQ35794484-5E4C12FD-45BF-4634-85C3-666811D39CCBQ35941465-971A8228-22D3-4D07-8AC1-70C952CEE441Q36018743-B364A489-5A4D-4A99-AFF7-24F2B710051AQ37901534-AC2672B2-00B9-4BB7-92D4-51E31D3E9EA7Q37973020-4952CD2D-A848-46E2-BB66-F568BD6BBE2EQ37989562-673B7C03-8144-4446-8C68-DD3FE70C5B0FQ38483558-77E5947B-C6B1-4868-BAD0-28573AF75E74Q39653780-66A2FB20-8175-4400-8FEC-23BF2B3C1A32Q40298087-9E9BFC70-FE89-4804-B2E4-53F50B8B6A17Q42151635-5F2F6112-4406-4C6C-8CA6-F445F5745399Q45731816-9842001E-0928-4399-AD55-6E1AF058CCEAQ48202863-C060F050-7080-445A-9DFA-FD20CE974045Q53671069-227090D7-24E4-41C6-A0C1-9E154E565848Q61815416-B42821BD-778F-426F-9926-140AAA8B63ADQ64107228-69390A2C-C739-44A6-AC70-97C70CCACF98Q64118615-DF6953CE-4B23-4777-95B5-38825647014FQ64227333-895C292D-530F-46A1-975A-EBF2CC763152Q64281494-6731EDC7-DDCF-49AB-8DEF-9228DD4D7C21Q83575109-19B2C3EF-0753-4412-A6DB-4C9CCBA3F949Q93329002-FCE7281A-E3FD-4570-9DDA-8D9BA591BCF2
P921
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Posaconazol
@de
Posaconazol
@es
Posaconazol
@ro
Posaconazole
@vi
Posakonazol
@sh
Posakonazol
@sl
Posakonazol
@sr
posaconazol
@pt
posaconazole
@en
posaconazole
@fr
type
label
Posaconazol
@de
Posaconazol
@es
Posaconazol
@ro
Posaconazole
@vi
Posakonazol
@sh
Posakonazol
@sl
Posakonazol
@sr
posaconazol
@pt
posaconazole
@en
posaconazole
@fr
altLabel
Posaconazole
@en
prefLabel
Posaconazol
@de
Posaconazol
@es
Posaconazol
@ro
Posaconazole
@vi
Posakonazol
@sh
Posakonazol
@sl
Posakonazol
@sr
posaconazol
@pt
posaconazole
@en
posaconazole
@fr
P2868
P31
P486
P6366
P662
P665
P683
P1748
P2017
CC[C@@H]([C@H](C)O)N1C(=O)N(C= ...... )(CN6C=NC=N6)C7=C(C=C(C=C7)F)F
P2067
700.329708
P2115
N0000176062
P2175
P231
171228-49-2